Cargando…
P1397: THIRD-PARTY MULTIVIRUS-SPECIFIC T CELLS FOR THE TREATMENT OF REFRACTORY VIRAL INFECTIONS AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION
Autores principales: | Yalcin, Koray, Erdogan, Ebru, Zengin, Rehile, Ozcelik, Tulay, Ozcelik Kurkcu, Nurcan, Ozdogu, Hakan, Kis, Cem, Sir Karakus, Gozde, Gunaydin, Selin, Seyis, Utku, Ratip, Siret, Ovali, Ercument |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430481/ http://dx.doi.org/10.1097/01.HS9.0000972476.61639.77 |
Ejemplares similares
-
In Vitro FVIII-Encoding Transgenic Mesenchymal Stem Cells Maintain Successful Coagulation in FVIII-Deficient Plasma Mimicking Hemophilia A
por: Hemşinlioğlu, Cansu, et al.
Publicado: (2023) -
Preliminary Report of the Academic CAR-T (ISIKOK-19) Cell Clinical Trial in Turkey: Characterization of Product and Outcomes of Clinical Application
por: Erdoğan, Ebru, et al.
Publicado: (2022) -
Preclinical Assessment of Efficacy and Safety Analysis of CAR-T Cells (ISIKOK-19) Targeting CD19-Expressing B-Cells for the First Turkish Academic Clinical Trial with Relapsed/Refractory ALL and NHL Patients
por: Taştan, Cihan, et al.
Publicado: (2020) -
Preclinical efficacy and safety analysis of gamma-irradiated inactivated SARS-CoV-2 vaccine candidates
por: Sir Karakus, Gozde, et al.
Publicado: (2021) -
Suprachoroidal spheroidal mesenchymal stem cell implantation in retinitis pigmentosa: clinical results of 6 months follow-up
por: Özkan, Berna, et al.
Publicado: (2023)